These results are in line with preclinical and retrospective clinical data indication increased sensitivity of PIK3CA‐mutated breast cancer to ET45, 46 and combined estrogen deprivation and PI3K inhibitors.25 The gene discussed is PIK3CA; the disease is breast carcinoma.